MTOR and cancer: In addition to MYC, the tumor suppressor p53, the oncogene KRAS, the mTOR-ATF4 axis, and the T-cell leukemia-associated R98S mutation have also been shown to promote Ser/Gly synthesis in cancer cells [167,168,169,170].